Adial Pharmaceuticals OverviewAdial Pharmaceuticals Operating Income
Operating Income for ADIL.
Quarterly Operating Income
$-2001481.00
↓ 11.72% YoY
As of Mar 31, 2026
Annual Operating Income (TTM)
$-7533650.00
↓ 13.47% YoY
Trailing 12 months ending Mar 31, 2026